Phase 2 Study of Rapcabtagene Autoleucel in Myositis

Clinical trial NCT06665256 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06665256
Sponsor: Novartis Pharmaceuticals
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Inflammatory Myopathies

Start date: 2024-12-17
Primary completion: 2029-03-09
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.